Serine proteases of malaria parasite plasmodium falciparum: Potential as antimalarial drug targets

23Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Malaria is a major global parasitic disease and a cause of enormous mortality and morbidity. Widespread drug resistance against currently available antimalarials warrants the identification of novel drug targets and development of new drugs. Malarial proteases are a group of molecules that serve as potential drug targets because of their essentiality for parasite life cycle stages and feasibility of designing specific inhibitors against them. Proteases belonging to various mechanistic classes are found in P. falciparum, of which serine proteases are of particular interest due to their involvement in parasite-specific processes of egress and invasion. In P. falciparum, a number of serine proteases belonging to chymotrypsin, subtilisin, and rhomboid clans are found. This review focuses on the potential of P. falciparum serine proteases as antimalarial drug targets. © 2014 Asrar Alam.

Cite

CITATION STYLE

APA

Alam, A. (2014). Serine proteases of malaria parasite plasmodium falciparum: Potential as antimalarial drug targets. Interdisciplinary Perspectives on Infectious Diseases. Hindawi Publishing Corporation. https://doi.org/10.1155/2014/453186

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free